Functional Groups in Drug Action: Hydrocarbons and Halides
Targeted Therapy: Daraxonrasib
- Daraxonrasib (Rasonque®, RMC-6236): An oral, non-covalent pan-RAS(ON) inhibitor developed by Revolution Medicines (Redwood City, CA).
- Regulatory Milestone: Approved by the FDA on August 26, 2026, as a first-in-class targeted therapy for metastatic pancreatic cancer.
- Historical Context: Prior to key structural insights published in 2013 on K-Ras(G12C) allosteric control (Ostrem et al.), RAS proteins were widely considered undruggable.

Hydrocarbon Architecture and Hybridization
- Alkanes ( Hybridization):
- Formed by mixing one and three atomic orbitals to yield four identical orbitals ( S, P character).
- Adopt a tetrahedral geometry with characteristic bond angles of .
- Ethane contains a C-C bond length of and H-C-C angles of .
- Boiling points scale directly with carbon chain length due to increased London dispersion interactions.

- Alkenes ( Hybridization):
- Hybridization of one and two orbitals creates three planar orbitals ( S, P character), leaving one unhybridized orbital at .
- Consists of one bond and one bond, creating a rigid planar center.
- Geometrical Isomerism: cis-Oleic acid (m.p. ) exhibits a lower melting point than trans-Oleic acid (m.p. ) due to poorer packing efficiency and diminished van der Waals contact.

- Cycloalkanes:
- Isomeric with alkenes (); slightly less hydrophobic and more rigid than open-chain counterparts.
- Serve as defined scaffolds to hold functional groups in precise spatial arrangements (e.g., cyclohexane chair conformation, cis/trans-Decalin, androstane).
Chemical Forces and Pharmacological Relevance
- Intermolecular vs. Intramolecular Forces:
- Intermolecular (between molecules): Dispersion (), Dipole-dipole (), Hydrogen bonding (), Ion-dipole ().
- Intramolecular (within molecules): Covalent bonds (), Ion-ion ().
- Zero attractive force is achievable only in ideal gases.

- Structure-Activity Relationship (SAR) of Alkyl Chains:
- Modifying linear alkyl chains on opioids significantly shifts agonist versus antagonist activity:
- (Morphine): Strong agonist.
- : Moderate agonist, weak antagonist.
- : Weak agonist, moderate antagonist.
- : Inactive.
- : Agonist potency that of morphine.
Aromatic Hydrocarbons and Metabolism
- Aromaticity Criteria:
- Cyclic, planar, fully conjugated -system conforming to Hückel's Rule ( -electrons).
- Enables key binding interactions with receptors via stacking and cation- interactions (e.g., Acetylcholine in nicotinic ACh receptors, Etomidate with Phe in receptors).
- Polycyclic Aromatic Hydrocarbons (PAHs):
- Fused ring systems without heteroatoms produced via incomplete combustion of fuel or organic matter (e.g., Benzo[a]pyrene / BaP).
- Bioactivated by CYP1A1/CYP1B1 and epoxide hydrolase into reactive diol epoxides (BPDE) that form carcinogenic DNA adducts at of adenine and of guanine.
!Metabolic activation of Benzo[a]pyrene to BPDE and formation of DNA adducts
- Hydrocarbon Metabolic Pathways:
- Aliphatic Oxidation: CYP450 enzymes hydroxylate alkanes at allylic, benzylic, or heteroatom-adjacent sites (e.g., Pentobarbital to 3-Hydroxy-pentobarbital).
- Deuteration Strategy: Replacing metabolically vulnerable C-H bonds with C-D bonds reduces oxidation rates up to 7-fold when C-H cleavage is rate-limiting (), prolonging drug half-life (e.g., Deutetrabenazine / Austedo®).
- Arene Hydroxylation: CYP450 oxidizes electron-rich aromatic rings. Electron-withdrawing groups and 6-membered heteroarenes decrease oxidation susceptibility, whereas 5-membered heteroarenes increase it (e.g., Phenylbutazone to Oxyphenbutazone; Phenytoin).
Halogenated Hydrocarbons in Medicinal Chemistry
- Physicochemical Effects:
- Halogens enhance lipophilicity, induce conformational bias, pull electron density inductively, and engage in halogen bonding.
- Fluorine is slightly larger than hydrogen; Chlorine is similar in steric size to a methyl group.

- Medicinal Applications of Halogenated Groups:
- Inert Modifiers: Paroxetine (Paxil®) and Chloramphenicol (Chloromycetin®) contain stable halogen substituents.
- Reactive Warheads: Melphalan (Alkeran®) utilizes a bis(chloroethyl)amine nitrogen mustard motif for DNA alkylation.
- Fluorine Properties: Highly electronegative, polarizes C-F bonds strongly, blocks metabolic soft spots, serves as a weak H-bond acceptor, and provides an avenue for PET radiolabeling (e.g., Lansoprazole, Celecoxib, Ciprofloxacin, Atorvastatin).
- Inhalational Anesthetics: Small hydrophobic halogenated compounds (Halothane, Sevoflurane, Desflurane, Isoflurane) modulate receptors; halogenated ethers replaced Halothane to prevent liver injury.